Nevin AL, Tülin ALKAN, Ayşen ÇAKIR, Mehmet CANSEV, Cansu KOÇ

Antioxidative effects of uridine in a neonatal rat model of hyperoxic brain injury

Background/aim: Premature birth is a major problem that results in an increased risk of mortality and morbidity. The management of such infants consists of supraphysiological oxygen therapy, which affects brain development due, in part, to the deterioration caused by reactive oxygen species (ROS). We showed previously that exogenously administered uridine provides neuroprotection in a neonatal rat model of hyperoxic brain injury. Hence, the aim of the present study was to investigate the effects of uridine on ROS in the same setting. Materials and methods: Hyperoxic brain injury was induced by subjecting a total of 53 six-day-old rat pups to 80% oxygen (the hyperoxia group) for a period of 48 h. The pups in the normoxia group continued breathing room air (21% oxygen). Normoxia + saline or hyperoxia + saline or hyperoxia + uridine 100 mg/kg or hyperoxia + uridine 300 mg/kg or hyperoxia + uridine 500 mg/kg was injected intraperitoneally (i. p.) 15 min prior to the hyperoxia procedure. The pups were decapitated and the brains were homogenized to analyze superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), myeloperoxidase (MPO), and malondialdehyde (MDA) enzymes as well as DJ-1 (protein deglycase DJ-1) — an oxidative stress-sensitive protein. Results: Hyperoxia-induced may cause overproduction of oxygen radicals and the oxidant/antioxidant balance may be disturbed in the brain. Brain MPO and MDA levels were significantly increased in saline-receiving pups exposed to hyperoxia. Brain SOD and GSHPx levels were significantly decreased in saline-receiving pups exposed to hyperoxia. Our results showed that uridine administration prevented the hyperoxia-induced decrease in SOD and GSH-Px while counteracting the hyperoxia-induced increase in MPO and MDA in a dose-dependent manner. Uridine also increased the DJ-1 levels in brains of rat pups subjected to hyperoxia. Conclusion: These data suggest that uridine exhibits antioxidative properties which may mediate the protective effects of uridine in a neonatal rat model of hyperoxic brain injury

PDF

___

1. Manuck TA, Rice MM, Bailit JL, Grobman WA, Reddy UM et al. Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort. American Journal of Obstetrics & Gynecology 2016; 215 (1): 103-114.
2. Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes, Mortality and acute complications in preterm infants Behrman RE, Butler AS, 2007. Preterm Birth: Causes, Consequences, and Prevention. 2007 National Academies Press Washington 313- 345.
3. Reich B, Hoeber D, Bendix I, Felderhoff-Mueser U. Hyperoxia and the immature brain. Developmental Neuroscience 2016; 38: 311-330.
4. Yis U, Kurul SH, Kumral A, Cilaker S, Tuğyan K et al. Hyperoxic exposure leads to cell death in the developing brain. Brain Development 2008; 30 (9): 556-562.
5. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ et al. Mitogenic signaling mediated by oxidants in Ras- transformed fibroblasts. Science 1997; 275 (5306): 1649-1652.
6. Lander HM. An essential role for free radicals and derived species in signal transduction. The FASEB Journal 1997; 11: 118-124.
7. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408: 239-247.
8. Fridovich I. Fundamental aspects of reactive oxygen species, or what’s the matter with oxygen? Annals of the New York Academy of Sciences 1999; 893: 13-18.
9. Bendix I, Schulze C, Haefen C, Gellhaus A, Endesfelder S et al. Erythropoietin modulates autophagy signaling in the developing rat brain in an in vivo model of oxygen-toxicity. International Journal of Molecular Sciences 2012; 13: 12939- 12951.
10. Felderhoff-Mueser U, Bittigau P, Sifringer M, Jarosz B, Korobowicz E et al. Oxygen causes cell death in the developing brain. Neurobiology of Disease 2004; 17: 273-282.
11. Volpe JJ. Perinatal brain injury: from pathogenesis to neuroprotection. Mental Retardation and Developmental Disabilities Research Reviews 2001; 7: 56-64.
12. Frank L, Sosenko IRS. Prenatal development of lung antioxidant enzymes in four species. Journal of Pediatrics 1987; 110 (1): 106-110.
13. Friel JK, Friesen RW, Harding SV. Roberts LJ. Evidence of oxidative stress in full-term healthy infants. Pediatric Resource 2004; 56: 878-882.
14. Tiina MA, Kari OR, Mika S, Vuokko LK. Expression and development profile of antioxidant enzymes in human lung and liver. American Journal of Respiratory Cell and Molecular Biology 1998; 19: 942-949.
15. Zaghloul N, Nasim M, Patel H, Codipilly C, Marambaud P et. al. Overexpression of extracellular superoxide dismutase has a protective role against hyperoxia-induced brain injury in neonatal mice. FEBS Journal 2012; 279: 871-881.
16. Perrone S, Tataranno ML, Stazzoni G, Buonocore G. Biomarkers of oxidative stress in fetal and neonatal diseases. The Journal of Maternal-Fetal & Neonatal Medicine 2012; 25: 2575-2578.
17. Sifringer M, Brait D, Weichelt U, Zimmerman G, Endesfelder S et al. Erythropoietin attenuates hyperoxia-induced oxidative stress in the developing rat brain. Brain, Behavior, and Immunity 2010; 24: 792-799.
18. Chisolm GM, 3rd Hazen SL, Fox PL, Cathcart MK. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. Journal of Biological Chemistry 1999; 274: 25959-25962.
19. Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clinical Chemistry 1995; 41 (12):1819-1828.
20. Endesfelder S, Makki H, von Haefen C, Spies CD, Buhrer C et al. Neuroprotective effects of dexmedetomidine against hyperoxia-induced injury in the developing rat brain. PLoS One 2017;12 (2): 1-20.
21. Cansev M. Uridine and cytidine in the brain: Their transport and utilization. Brain Resource 2006; 52 (2): 389-397.
22. Wurtman RJ, Regan M, Ulus IH, Yu L. Effect of oral CDPcholine on plasma choline and uridine levels in humans. Biochemical Pharmacology 2000; 60: 989-992.
23. Thorell L, Sjoberg LB, Hernell O. Nucleotides in human milk: sources and metabolism by the newborn infant. Pediatric Research 1996; 40 (6): 845-852.
24. Kennedy EM, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipids. Journal of Biological Chemistry. 1956; 222: 193-214.
25. Cansev M, Minbay Z, Goren B, Yaylagul EO, Cetinkaya M et al. Neuroprotective effects of uridine in a rat model of neonatal hypoxicischemic encephalopathy. Neuroscience Letters. 2013; 542: 65-70.
26. Goren B, Cakir A, Ocalan B, Kocoglu SS, Alkan T, Cansev M. Long-term cognitive effects of uridine treatment in a neonatal rat model of hypoxic- ischemic encephalopathy encephalopathy. Brain Resource 2017; 1659: 81-87.
27. Koyuncuoğlu T, Türkyılmaz M, Gören B, Cetinkaya M, Cansev M et al. Uridine protects against hypoxic-ischemic brain injury by reducing histone deacetylase activity in neonatal rats. Restorative Neurology and Neuroscience 2015; 33 (5): 777-784.
28. Goren B, Cakir A, Sevinc C, Kocoglu S, Ocalan B et al. Uridine treatment protects against neonatal brain damage and longterm cognitive deficits caused by hyperoxia. Brain Research 2017; 1676: 57-68.
29. Bendix I, Weichelt U, Strasser K, Serdar M, Endesfelder S et al. Hyperoxia changes the balance of the thioredoxin/ peroxiredoxin system in the neonatal rat brain. Brain Resource 2012; 1484: 68-75.
30. Endesfelder S, Zaak I, Weichelt U, Bührer C, Schmitz T. Caffeine protects neuronal cells against injury caused by hyperoxia in the immature brain. Free Radical Biology and Medicine 2014; 67: 221-234.
31. Sifringer M, von Haefen C, Krain M, Paeschke N, Bendix I et al. Neuroprotective effect of dexmedetomidine on hyperoxiainduced toxicity in the neonatal rat brain. Oxidative Medicine and Cellular Longevity 2015; 1-10.
32. Clancy B, Darlington RB, Finlay BL. Translating developmental time across mammalian species. Neuroscience 2001; 105 (1): 7-17.
33. Ritter J, Schmitz T, Chew LJ, Bührer C, Möbius W et al. Neonatal Hyperoxia Exposure Disrupts Axon–Oligodendrocyte Integrity in the Subcortical White Matter. Journal of Neuroscience 2013; 33 (21): 8990-9002.
34. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-689.
35. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folinphenol reagents. Journal of Biological Chemistry 1951; 193: 265-275.
36. Marlow N, Wolke D, Bracewell MA, Samara M, Group ES. Neurologic and developmental disability at six years of age after extremely preterm birth. New England Journal of Medicine 2005; 352: 9-19.
37. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. New England Journal of Medicine 2000; 343: 378-384.
38. Sola A, Golombek SG, Montes Bueno MT, Lemus-Varela L, Zuluaga C et al. Safe oxygen saturation targeting and monitoring in preterm infants: can we avoid hypoxia and hyperoxia? Acta Paediatrica 2014; 103 (10): 1009-1018.
39. Giannone PJ, Bauer JA, Schanbacher BL, Reber KM. Effects of hyperoxia on postnatal intestinal development. Biotech Histochem 2007; 82 (1): 17-22.
40. Gien J, Kinsella JP. Pathogenesis and treatment of bronchopulmonary dysplasia. Current Opinion in Pediatrics 2011; 23: 305-313.
41. Perrone S, Vezzosi P, Longini M, Marzocchi B, Paffetti P et al. Biomarkers of oxidative stress in babies at high risk for retinopathy of prematurity. Frontiers in Bioscience 2009; 1: 547-552.
42. Saugstad OD. Oxygen and retinopathy of prematurity. Journal of Perinatology 2006; 26: 46-50.
43. Collins MP, Lorenz JM, Jetton JR, Paneth N. Hypocapnia and other ventilation-related risk factors for cerebral palsy in low birth weight infants. Pediatric Resource 2001; 50: 712-719.
44. Kumar VH, Patel A, Swartz DD, Wang H, Wynn KA et al. Exposure to supplemental oxygen and its effects on oxidative stress and antioxidant enzyme activity in term newborn lambs. Pediatric Resource 2010; 67: 66-71.
45. Patel A, Lakshminrusimha S, Ryan RM, Swartz DD, Wang H et al. Exposure to supplemental oxygen downregulates antioxidant enzymes and increases pulmonary arterial contractility in premature lambs. Neonatology 2009; 96:182- 192.
46. Brehmer F, Bendix I, Prager S, van de Looij Y, Reinboth, BS et al. Interaction of inflammation and hyperoxia in a rat model of neonatal white matter damage. PLoS One 2012; 7: 1-13.
47. Sifringer M, Genz K, Brait D, Brehmer F, Löber R et al. Erythropoietin attenuates hyperoxia-induced cell death by modulation of inflammatory mediators and matrix metalloproteinases. Developmental Neuroscience 2009; 31: 394-402.
48. Yis U, Kurul SH, Kumral A, Tugyan K, Cilaker S et al. Effect of erythropoietin on oxygen-induced brain injury in the newborn rat. Neuroscience Letters 2008; 448: 245-249.
49. Kurul SH, Yis U, Kumral A, Tuğyan K, Cilaker S et al. Protective effects of topiramate against hyperoxic brain injury in the developing brain. Neuropediatrics 2009; 40: 22-27.
50. Sifringer M, Bendix I, von Haefen C, Endesfelder S, Kalb A et al. Oxygen toxicity is reduced by acetylcholinesterase inhibition in the developing rat brain. Developmental Neuroscience 2013; 35: 255-264.
51. Kim YE, Park WS, Sung DK, Ahn SY, Sung SI et al. Intratracheal transplantation of mesenchymal stem cells simultaneously attenuates both lung and brain injuries in hyperoxic newborn rats. Pediatric Research 2016; 80: 415-424.
52. Serdar M, Herz J, Kempe K, Lumpe K, Reinboth BS et al. Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia. Brain, Behavior, and Immunity 2016; 52: 106-119.
53. Cicko S, Grimm M, Ayata K, Beckert J, Meyer A et al. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis. Respiratory Research 2015; 16: 105-115.
54. Evaldsson C, Ryden I, Uppugunduri S. Anti-inflammatory effects of exogenous uridine in an animal model of lung inflammation. International Immunopharmacology 2007; 7: 1025-1032.
55. Jeengar MK, Thummuri D, Magnusson M, Naidu VGM, Uppugunduri S. Uridine Ameliorates Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice. Scıentıfıc Reports 2017; 7: 3924, 1-10.
56. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003; 299: 256-259.
57. Jin J, Meredith GE, Chen L, Zhou Y, Xu J et al. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson’s disease. Molecular Brain Research 2005; 134:119-138.
58. Lev N, Ickowicz D, Melamed E, Offen D. Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection. Neurotoxicology 2008; 29: 397-405.
59. Lev N, Ickowicz D, Barhum Y, Lev S, Melamed E et al. DJ-1 protects against dopamine toxicity. Journal Neural Transmission. 2009; 116: 151-160.
60. Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H et al. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochemical and Biophysical Research Communications 2003; 312: 1342-1348.